1139717-76-2

Basic information

• Product Name: 3-(4-methylpiperazin-1-yl)phenylboronic acid
• Synonyms: 3-(4-methylpiperazin-1-yl)phenylboronic acid;3-(4-Methyl-1-piperazinyl)phenylboronic Acid;3-(4-methylpiperazinyl)phenyl boronic acid;B-[3-(4-methyl-1-piperazinyl)phenyl]Boronic acid
• CAS NO: 1139717-76-2
• Molecular Formula: C₁₁H₁₇BN₂O₂
• Molecular Weight: 220.07588
• Product Categories: Boronate Ester;Boronic Acid;Potassium Trifluoroborate
• Mol File: 1139717-76-2.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 417.7±55.0 °C(Predicted)
• Appearance: /
• Density: 1.20
• PKA: 8.79±0.10(Predicted)
• CAS DataBase Reference: 3-(4-methylpiperazin-1-yl)phenylboronic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(4-methylpiperazin-1-yl)phenylboronic acid(1139717-76-2)
• EPA Substance Registry System: 3-(4-methylpiperazin-1-yl)phenylboronic acid(1139717-76-2)

Safety Data

• Hazardous Substances Data: 1139717-76-2(Hazardous Substances Data)

Usage

General Description

3-(4-methylpiperazin-1-yl)phenylboronic acid is a chemical compound that consists of a phenylboronic acid group attached to a 4-methylpiperazin-1-yl group. It is commonly used as a reagent in organic synthesis and medicinal chemistry. The phenylboronic acid group is known for its ability to form stable complexes with diols, making it useful in the synthesis of pharmaceuticals and agrochemicals. The 4-methylpiperazin-1-yl group is a versatile building block in drug design, often used to enhance the pharmacokinetic properties of pharmaceuticals. The combination of these two groups in 3-(4-methylpiperazin-1-yl)phenylboronic acid makes it a valuable chemical tool in the development of new drugs and research in medicinal chemistry.

Upstream product

• 108-36-1 1,3-dibromobenzene 
• 109-01-3 1-methyl-piperazine 
• 747413-17-8 1-bromo-3-(4-methylpiperazin-1-yl)benzene 
• 5419-55-6 Triisopropyl borate 

Downstream Products

• 1350659-91-4 8-fluoro-4-[5-[3-(4-methylpiperazin-1-yl)phenoxy]pyrimidin-2-yl]-3,4-dihydro-2H-benzo[1,4]oxazine 
• 1200126-42-6 3-(3-(4-methylpiperazin-1-yl)phenyl)-9H-pyrrolo[2,3-b:5,4-c′]-dipyridine-6-carbonitrile 

Relevant articles and documents

COMPOUNDS

A compound of formula (I) or a pharmaceutically acceptable salt or prodrug thereof wherein X is N or CH; Q is NR6 or O; A1 and A2 are independently hydrogen or C1-6 alkyl or may together form a carbonyl group; R1 and R2 are independently hydrogen, halogen, CF3, CN, OR7, OR8, NR8R9, NR8COR10, NR8S02R10, S02NR8R9, SO2R10 or C1-6 alkyl optionally and independently substituted by one or more of hydroxyl, C1-6 alkoxy, halogen or NR8 R9; R 3 is hydrogen, halogen, CF3 or OR 7; R4 is hydrogen, halogen, CF3, OR8, NR8R9, NR8COR10, NR8S02R10 or C1-6 alkyl optionally substituted by hydroxyl, C1-6 alkoxy or NR 8 R 9; or when R3 and R4 are positioned ortho and taken together form -0(CH2)mO-, where m is 1-3; R5 is hydrogen or C1-6 alkyl optionally substituted by hydroxyl, C1-6 alkoxy or NR8 R9; R6 is hydrogen or C1-6 alkyl; R7 is hydrogen or C1-6 alkyl optionally substituted by OR8 or NR8R9; R8 is hydrogen, C1-6 alkyl, optionally substituted by hydroxyl or C1-6 alkoxy or C1-3 alkylphenyl wherein said phenyl group is optionally substituted by one or more substituents selected from halogen, C1-6 alkyl, CF3, OR7, NR8R9 or OCF3; or the groups R8 and R9 when they are attached to a nitrogen atom may together form a 5- or 6-membered ring which optionally contains one further heteroatom selected from NR7, S and O said 5 or 6 membered ring being optionally substituted by hydroxyl or C1-6 alkoxy; or the groups R8 and R9 when they are attached to a nitrogen atom may together form an azetidinyl ring optionally substituted by hydroxyl or C1-6 alkoxy; and R10 is C1-6 alkyl or a phenyl group optionally substituted by one or more substituents selected from halogen, C1-6 alkyl, CF3, OCF3 or OR7; and n is 1 or 2. The use of the compounds in treating amyloid disease is also disclosed.